Exploring lipid metabolism: A journey through time and innovation
Year after year, groundbreaking research in lipid metabolism fuels new discoveries, transforming our understanding of cellular function and unlocking potential treatments for metabolic disorders and neurodegenerative diseases. At the American Society for Biochemistry and Molecular Biology annual meetings, scientists come together to share the latest breakthroughs — each study building on the last — to push the boundaries of what’s possible in basic research and clinical innovation.

Membrane dynamics and lipid–protein interactions
Lipid–protein interactions are central to maintaining cell membrane integrity, signaling, and protein activity. Disruptions in these interactions have been linked to diseases like Alzheimer's, cardiovascular disorders and autoimmune diseases, making them crucial targets for therapeutic research.
One notable 2022 abstract used cryogenic electron microscopy to explore ABHD5, a regulator of lipid homeostasis. This research revealed how ABHD5 interacts with lipids and regulates adipose triglyceride lipase activity, which is essential for lipid breakdown and energy balance. Mutations in ABHD5 can lead to nonalcoholic fatty liver disease, or NAFLD. Therefore, this research lays a foundation for potential NAFLD gene therapies.
In the same year, an abstract on NAFLD investigated oxidized phospholipids that are recognized by an antibody. The researchers used a viral vector to express the antibody in the liver, which protected mice from liver damage and fibrosis. This suggests that oxidized phospholipids could serve as biomarkers for NAFLD and offers new therapeutic possibilities targeting lipid abnormalities.
Building on foundational phospholipid research from previous years, a 2024 abstract examined how extracellular crowding agents affect the membrane binding of antimicrobial peptides like Buforin II. This discovery informs researchers on how to design more effective peptides to combat pathogens.
Another 2024 abstract explored lipid rafts — specialized membrane regions — and their impact on the human follicle-stimulating hormone receptor, or hFSHR, crucial for fertility. Mutations in the receptor motif that binds the membrane protein caveolin disrupted signaling, impairing spermatogenesis. These findings emphasize the importance of lipid–protein interactions in cellular function and health.
These studies advance lipid science by examining how lipids and proteins interact to influence cellular function and disease progression. Lipidomics research highlights the diagnostic potential of specific lipid species, while studies on caveolae — lipid-rich membrane domains — demonstrate how membrane structure regulates signaling pathways. Furthermore, research on oxidized phospholipids connects these molecules to oxidative stress in NAFLD, while investigations into the membrane protein caveolin reveal its role in controlling stress-related signaling.
By targeting these lipid–protein interactions, researchers may unlock new therapeutic strategies for NAFLD, reproductive disorders and endothelial dysfunction.
Future of lipid science
Lipid metabolism research is evolving quickly, with breakthroughs reshaping our understanding of cellular function, disease progression and treatment options. Whether you're a researcher, clinician or science enthusiast, ASBMB meetings provide a unique opportunity to engage with the latest advancements in lipid science.
Stay up to date with the field and join us in shaping the future of lipid metabolism research. Register for the ASBMB annual meeting and be part of this exciting journey.
For lipid-focused sessions at #ASBMB25, check out the symposium on lipids and membranes, organized by Gerry Hammond of the University of Pittsburgh and Judith Simcox of the University of Wisconsin–Madison.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.

Omega-3 lowers inflammation, blood pressure in obese adults
A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.